Amgen Argues For Review Of Statute Interpretation By High Court In Patent Case
WASHINGTON, D.C. — Amgen Inc. and Amgen Manufacturing Limited (Amgen, collectively) on March 21 asked the U.S. Supreme Court to review an appellate court’s conclusion that the word "shall" in a...To view the full article, register now.
Already a subscriber? Click here to view full article